What is the appropriate Bactrim (sulfamethoxazole/trimethoprim) dosing for a 12-year-old patient weighing 106 lb (≈48 kg) with a MRSA skin infection?

Bactrim Dosing for 12-Year-Old with MRSA Skin Infection (106 lbs/48 kg)

For a 12-year-old weighing 106 lbs (48 kg) with a MRSA skin infection, administer trimethoprim-sulfamethoxazole (Bactrim) at 8-12 mg/kg/day of the trimethoprim component divided into 2 doses (every 12 hours), which translates to approximately 1.5 to 2 double-strength tablets twice daily for 7-10 days.

Dosing Calculation

Based on the IDSA guidelines for MRSA skin and soft tissue infections 1:

• Pediatric dosing: 8-12 mg/kg/day based on trimethoprim component, divided into 2 doses (every 12 hours)

• For this 48 kg patient:

  • Lower range: 8 mg/kg/day × 48 kg = 384 mg/day trimethoprim (192 mg per dose)
  • Upper range: 12 mg/kg/day × 48 kg = 576 mg/day trimethoprim (288 mg per dose)

• Practical dosing using available formulations:

  • 1.5 double-strength (DS) tablets twice daily = 240 mg trimethoprim per dose (480 mg/day total) = 10 mg/kg/day
  • 2 DS tablets twice daily = 320 mg trimethoprim per dose (640 mg/day total) = 13.3 mg/kg/day

The optimal choice is 1.5 DS tablets (240 mg TMP/1200 mg SMX) twice daily, which provides 10 mg/kg/day and falls comfortably within the guideline range 1.

Duration of Therapy

• 7-10 days is appropriate for uncomplicated MRSA skin infections 1
• For MRSA abscesses specifically, 10 days is superior to 3 days in reducing treatment failure (10.1% difference) and recurrence rates 2
• Individualize based on clinical response, but err toward 10 days for purulent infections

Key Clinical Considerations

Type of infection matters:

• Purulent infections (abscesses, furuncles): Incision and drainage is the primary treatment; antibiotics are adjunctive 3
• Non-purulent cellulitis: Consider that MRSA may not be the pathogen; β-hemolytic streptococci are common, and Bactrim lacks streptococcal coverage 1

Dosing nuances from recent evidence:

• The FDA label 4 lists a broader range (40 mg/kg/day SMX with 8 mg/kg/day TMP) for general pediatric infections, but IDSA guidelines specifically for MRSA recommend the 8-12 mg/kg/day TMP range 1
• Recent pharmacokinetic studies 5 support 8-12 mg/kg/day (divided every 12 hours) as achieving adequate tissue concentrations for MRSA with MIC ≤0.5 mg/L
• Higher doses (12-15 mg/kg/day) are NOT necessary for skin infections and increase adverse events without improving outcomes 6, 7

Common Pitfalls to Avoid

1. Don't use adult dosing: Adult dosing (1-2 DS tablets twice daily) significantly underdoses larger children and adolescents
2. Don't forget surgical drainage: For abscesses, antibiotics alone have inferior outcomes; drainage is essential 3
3. Monitor for adverse effects: Bactrim has higher adverse event rates in children compared to alternatives like clindamycin 7, including rash, GI upset, and rarely blood dyscrasias
4. Check local resistance patterns: Ensure local MRSA clindamycin resistance is >10% before choosing Bactrim over clindamycin 3
5. Avoid monotherapy for non-purulent cellulitis: If streptococcal infection is possible, add β-lactam coverage (e.g., amoxicillin) 3

Alternative Considerations

If Bactrim is not tolerated or contraindicated:

• Clindamycin: 30-40 mg/kg/day divided into 3 doses (if local resistance <10%) 1
• Doxycycline: 100 mg twice daily (acceptable at age 12) 1
• Linezolid: 600 mg twice daily for age ≥12 years (reserve for severe cases due to cost and adverse effects) 3